SOX2 and non-small cell lung carcinoma: Notwithstanding, in non-small cell lung carcinoma (NSCLC), SOX2 overexpression was associated with a better prognostic course in only squamous cell carcinoma [58,60] and both squamous cell carcinoma and adenocarcinoma [42,57].